ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 698931 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 698931; 2) Community: the network communities that were significantly associated with the response to NSC 698931; 3) Molecule: the relationships between components within communities and NSC 698931; 4) MDR: the compounds that were significantly associated with the NSC 698931.

NSC Compound Enrichment Correlation
NSC 699427 Null 0.00206000157707805 0.21618511
NSC 708854 Null 0.00206000157707805 0.40131335
NSC 709098 Null 0.00206000157707805 0.24257048
NSC 710969 Carbonotrithioic acid, 2,3,5,6-tetrachloro-4-pyridinyl-, 1-methylethyl ester 0.00206000157707805 0.21830674
NSC 715664 Phenol, 4-(5,6-dimethyl-1H-benzimidazol-2-yl)- 2,6-bis(1,1-dimethylethyl)- 0.00206000157707805 0.45625685
NSC 722779 dabequine 0.00206000157707805 0.20219913
NSC 724794 5-Benzyl-9-hydroxy-5H-indeno[1,2-b]indol-10-one 0.00206000157707805 -0.13012259
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.00206000157707805 0.43001549
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.00206000157707805 0.38489209
NSC 731155 6-(3-Aminopropyl)-5,6-dihydro-5,11-dioxo-3-nitro-11H-indeno[ 1,2-c]isoquinoline Hydrochloride salt 0.00206000157707805 0.4881967
Total:202  Current:27    [First] [Prev] [Next] [Last]